Antibiotic Commercial Models Under Revision To Tackle Stewardship Tension
Executive Summary
Large pharma companies like AstraZeneca and GSK tout a project to devise new antibiotic development strategies that are independent of sales volumes, while some companies say stewardship and a sales-based system can go hand in hand.